Drug Discovery

Scientists develop treatment that leads to complete regression of breast tumors in mice.

Stakeholders explain why the NIH’s move to cap indirect costs associated with research grants could damage medical innovation.

Review shows that antidepressants have significant effect when treating generalized anxiety disorder.

How snake venom, genomic data, and deep learning computation methods have combined to bring new advances in drug discovery.

With new cases of avian influenza appearing, what does this mean for global health and what are drug developers doing about it?

Using AI to improve oncology care and find the right clinical trials for patients.

How understanding and manipulating senescence dynamics could optimize cancer therapies and improve patient outcomes.

How can you ensure your gene therapy research won’t be slowed down by synthesis problems?

Sitting Down With… Matthew Durdy, Chief Executive, Cell and Gene Therapy Catapult.

How unified assay protocols and advanced bioinformatics are refining our understanding of mitochondrial dysfunction in complex diseases.